CTRI/2021/12/038615尚未招募未知
A double blind, placebo controlled, parallel group, prospective clinical study to evaluate the effects of FSFW0121 on appetite and weight management in overweight/obese subjects.
Akay Natural Ingredients Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Body Mass Index higher than 25 up to 35 kg/m2
- •2.currently not involved in any weight loss program or weight loss treatment
- •3.No history of allergic to herbal products
- •4. Non Smoker
- •5. Willing to provide written informed consent
排除标准
- •1.Subjects having symptoms of viral infection, including COVID-19 infection
- •2.Subjects with Clinically significant comorbidity
- •3.History of clinically significant illness or any other medical disorder that may interfere with subject treatment, assessment or compliance with the protocol.
- •4.Subjects currently on any other dietary supplementation
- •5.Visually or mentally handicapped
- •6.Any other condition that in the view of the investigator renders the subject inappropriate for enrolment
研究者
相似试验
进行中（未招募）
不适用
A double blind, placebo controlled, parallel group study with an open label reference arm to assess the effects of intravenously administered AIN457 on ozone induced neutrophilia compared to placebo and oral corticosteroid in healthy volunteersHealthy volunteersEUCTR2008-002854-39-DEovartis Pharma Services AG24
进行中（未招募）
不适用
A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release formulations of UK-369,003 and Cialis compared to placebo in adult male subjects with erectile dysfunction. - N/AMale Erectile DysfunctionEUCTR2004-001955-12-DEPfizer Pharma GmbH335
进行中（未招募）
1 期
STEMALS-IIEUCTR2014-002228-28-ITniversità degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino90
尚未招募
不适用
A clinical study to evaluate the safety and efficacy of VISPO in healthy subjects.CTRI/2021/12/038621Vidya Herbs Pvt Ltd
进行中（未招募）
1 期
A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release formulations of UK-369,003 and Cialis compared to placebo in adult male subjects with erectile dysfunction. - N/AMale Erectile DysfunctionEUCTR2004-001955-12-ESpfizer s.a335